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Abstract
Oncogenes induce cell proliferation leading to replicative stress, DNA damage and genomic instability. A wide variety of
cellular stresses activate c-Jun N-terminal kinase (JNK) proteins, but few studies have directly addressed the roles of JNK
isoforms in tumor development. Herein, we show that jnk2 knockout mice expressing the Polyoma Middle T Antigen
transgene developed mammary tumors earlier and experienced higher tumor multiplicity compared to jnk2 wildtype mice.
Lack of jnk2 expression was associated with higher tumor aneuploidy and reduced DNA damage response, as marked by
fewer pH2AX and 53BP1 nuclear foci. Comparative genomic hybridization further confirmed increased genomic instability in
PyV MT/jnk22/2 tumors. In vitro, PyV MT/jnk22/2 cells underwent replicative stress and cell death as evidenced by lower
BrdU incorporation, and sustained chromatin licensing and DNA replication factor 1 (CDT1) and p21
Waf1 protein expression,
and phosphorylation of Chk1 after serum stimulation, but this response was not associated with phosphorylation of p53
Ser15. Adenoviral overexpression of CDT1 led to similar differences between jnk2 wildtype and knockout cells. In normal
mammary cells undergoing UV induced single stranded DNA breaks, JNK2 localized to RPA (Replication Protein A) coated
strands indicating that JNK2 responds early to single stranded DNA damage and is critical for subsequent recruitment of
DNA repair proteins. Together, these data support that JNK2 prevents replicative stress by coordinating cell cycle
progression and DNA damage repair mechanisms.
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Introduction
Numerous oncogenes including ErbB2, EGFR (Epidermal
Growth Factor Receptor), and IGF-1R (Insulin-like Growth
Factor 1 Receptor) have been therapeutically targeted in the past
two decades. The tyrosine kinase receptors (TKRs) increase
activity of the PI3K (Phosphatidylinositol 3-Kinase) and Ras/Shc/
MAPK pathways to enhance cell proliferation and suppress
apoptosis. Ironically however, oncogene induced replicative or
oxidative stress can also result in senescence as a barrier to tumor
progression [1]. Understanding the differential signaling mecha-
nisms that influence proliferative versus senescent outcomes is
essential for inhibiting oncogene driven tumor growth without
adversely affecting tumor barriers. JNK is frequently a down-
stream mediator of TKR responses. The Polyoma Middle T
Antigen (PyV MT) oncogene activates PI3K and Shc/MAPK
dependent pathways, and induces c-Jun phosphorylation (via JNK
activation) and transcriptional activity [2]. Moreover, the Met
oncogene mediates transformation via PI3K and JNK [3]. These
studies maintain that TKR induced JNK/c-Jun activity enhances
tumorigenesis. C-Jun may be essential to this process since c-jun
deficient cells undergo premature senescence resulting from DNA
damage accumulation and inefficient repair [4]. Targeting c-Jun
for cancer prevention or treatment presents many challenges given
its ubiquitous function in cells. In contrast, the upstream mediators
of c-Jun may be attractive targets. To date, no studies have
addressed the specific functions of the various JNK proteins in
TKR mediated cancer progression. The PyV MT mouse
mammary tumor model closely emulates both early and late
stages of human breast cancer and serves as an excellent model to
address such questions [5].
JNK proteins are known mediators of growth factor responses
but this area is understudied compared to other types of stimuli.
Notably, JNKs convey downstream messages from a wide-variety
of important cancer related proteins including Ras, PI3K, Rac1,
and PTEN (Phosphatase and Tensin homolog) [6,7]. JNK proteins
were thought to be required for Ras mediated transformation in
vitro but were found unnecessary in an in vivo model using Ras
transformed compound jnk12/2/jnk22/2 3T3 fibroblasts [8].
Inhibition of basal JNK activity in established breast cancer cell
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These data support the need to mechanistically study the
involvement of JNK proteins using spontaneous tumor models.
While JNK proteins are generally considered stress induced
kinases, understanding the biological contributions of the three jnk
genes and resulting ten isoforms has been challenging. In many
instances genetic knockout and shRNA approaches are needed to
elucidate the specific functions of the products of the three jnk
genes. While compound knockout of jnk1 and jnk2 is embryonic
lethal, single knockouts are viable, suggesting that jnk1 and jnk2
may possess redundant functions during development. MEFs
(Mouse Embryo Fibroblasts) are largely used to study the specific
and combined jnk1 and jnk2 mediated phenotypes and signaling
pathways. These studies have formed the basis of our knowledge
for the diverse roles of JNK proteins. However, tissue specific
models are required to recapitulate pathogenesis of various
diseases including cancer, metabolic, cardiovascular and neuro-
logical diseases. Moreover, animal models are essential in
providing information on processes such as susceptibility to
tumorigenesis. Studies using single jnk1 or jnk2 knockout mice
have provided insight into isoform specific functions of JNK
proteins in diseases like leukemia, skin tumorigenesis and insulin
resistant diabetes [10,11,12,13,14]. In these cases, disparate
phenotypes between jnk1 and jnk2 knockouts were observed.
JNK proteins phosphorylate diverse substrates but many of JNKs’
functions are thought to revolve around their ability to phosphorylate
c-Jun and induce AP-1 dependent transcription. When phosphor-
ylated, c-Jun participates in the AP-1 dimer, increasing gene
expression of c-myc and cyclin D in mammary epithelial cells
[15]. Overexpression of non-phosphorylatable c-Jun has demon-
strated important functions in both cancer and mammary gland
development due to proliferation defects [15]. By phosphorylating
substrates other than c-Jun, including IRS-1, Bcl-2 related proteins
or FOXO transcription factors, JNK proteins play integral roles in a
variety of cellular responses like cell death and senescence [16,17].
Here, we show that systemic deletion of jnk2 in the PyV MT
transgenic mouse model shortens tumor latency and increases
tumor multiplicity. Additionally, PyV MT/jnk22/2 mammary
tumors have a significantly higher frequency of aneuploidy than
the PyV MT/jnk2+/+ controls but show reduced DNA damage
response markers. In vitro studies comparing PyV MT/jnk22/2
and PyV MT/jnk2+/+ cells show that re-initiation of the cell cycle
is associated with increased p21
Waf1 expression and cell death,
with minimal changes in p53 response. Overexpression of CDT1
further confirms that PyV MT/jnk22/2 are more susceptible to
replicative stress and subsequent cell death. In summary, our data
unveil important functions for jnk2 in tumorigenesis, replicative
stress response and cancer cell survival.
Results
Jnk2 knockout shortens tumor latency and increases
tumor multiplicity induced by the PyV MT transgene
In the studies presented herein, we set out to assess the
contributions of JNK2 isoforms in mammary tumorigenesis and
metastasis using the MMTV-PyV MT transgenic mouse model
[18]. PyV MT mice were backcrossed to the Balb/C strain for
over 10 generations and were then mated with jnk22/2 mice to
obtain PyV MT/jnk2+/+, PyV MT/jnk2+/2 and PyV MT/
jnk22/2 genotypes. Female transgenic mice were palpated for
tumors three times weekly. During the time of observation, PyV
MT/jnk22/2 mice developed palpable tumors earlier than the
PyV MT/jnk2+/+ mice (median time to first tumor palpation,
T50=day 55 vs. day 70, respectively). PyV MT/jnk2+/2 mice
experienced an intermediate latency, demonstrating that tumor
latency increased incrementally with jnk2 expression (Figure 1A).
Importantly, PyV MT/jnk22/2 mice also experienced signifi-
cantly higher numbers of tumors per mouse (i.e. tumor
multiplicity), and the heterozygous mice showed an intermediate
tumor multiplicity (Figure 1B). These data support that loss of jnk2
expression facilitates tumorigenesis by shortening tumor latency
and increasing tumor multiplicity.
Assessment of tumor apoptotic indices using cleaved caspase 3
immunohistochemistry showed no difference between the PyV
MT/jnk2+/+ and the PyV MT/jnk22/2 tumors (Figure 1C). In
contrast, the percent of cells staining positive for Ki-67, a marker
of cell proliferation, was significantly higher in the PyV MT/
jnk2+/+ tumors compared to the PyV MT/jnk22/2 (Figure 1D).
This finding correlated with the intensity and frequency of
phosphorylated c-Jun in tumor cells which was notably higher in
the PyV MT/jnk2+/+ tumors (Figure 1E). Together, these data
support that the loss of jnk2 expression facilitates tumorigenesis as
shown by shortened latencies and higher tumor multiplicity.
However, once tumors developed the jnk2 knockout tumors
showed less cell proliferation and reduced c-Jun phosphorylation.
Absence of jnk2 increases tumor aneuploidy
We then focused our studies more closely on the potential
mechanism(s) by which jnk2 deletion enhances tumorigenesis. Loss
of cell cycle checkpoints during replication can result in
amplification or deletion of various genes and genomic instability.
Moreover, inhibition of basal JNK causes endoreduplication in
breast cancer cell lines [9]. Given that tumor development was
facilitated in PyV MT/jnk2 knockout mice, we evaluated whether
there was a difference in ploidy between the PyV MT/jnk2+/+
and the PyV MT/jnk22/2 tumors. To this end, tumors were
harvested and primary mammary tumor cells were cultured. Early
passage primary tumor cells (passages 2 or 3) were harvested and
processed for cell cycle analysis using propidium iodide (PI)
staining. PyV MT/jnk22/2 tumors showed significantly higher
percentages of cells with $4N DNA content compared to the PyV
MT/jnk2+/+ tumors (Figure 2A), consistent with the presence of
tetraploid or aneuploid tumor cells in the jnk2 deficient tumors.
Cell cycle analysis using PI staining does not allow discrimination
between 4N diploid and 2N tetraploid populations of cells and is also
unable to detect losses or gains of only a few chromosomes.
Therefore, the number of chromosomes in each metaphase spread
was counted using the same set of tumors. Figure 2B illustrates that
the number of chromosomes per metaphase in the PyV MT/jnk2+/+
tumors was more frequently diploid compared to the PyV MT/
jnk22/2 tumors. Each tumor is represented by a specific color (listed
as mouse number and number of metaphase spreads counted per
tumor in the legend). While aneuploidy was rather common in both
groups, it was significantly more frequent in the PyV MT/jnk22/2
tumors. Together, these data are consistent with the conclusion that
loss of jnk2 expression increases tumor aneuploidy in this model.
Loss of p53 function frequently leads to tumorigenesis, and
aneuploidy contributes to this effect. Mutations or deletion of p53
often precede aneuploidy. Mutant p53 protein in more stable and
frequently shows notably higher expression than wildtype p53
protein. Thus, p53 expression was measured to determine if its
deletion or mutation is associated with the aneuploidy observed in
the jnk2 knockout tumors. Western blot analysis of PyV MT tumor
lysates showed that p53 expression was very low and similar with
both genotypes (Figure 2C). These data are consistent with wildtype
p53 expression and indicate that p53 expression is not changed in
the absence of jnk2. Therefore, genetic deletion or mutation of p53
is not likely contributing to aneuploidy in this model.
JNK2 in Replicative Stress
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Alternatively, DNA damage due to oncogene driven proliferation
can impair cell cycle checkpoints and/or result in oxidative stress.
Given the increase in aneuploidy in the PyV MT/jnk22/2 tumors,
we evaluated these tumors for signs of DNA damage. ATM
phosphorylates Ser139 of H2AX in response to double strand breaks
(DSB). Phosphorylated H2AX (pH2AX) then localizes to DSBs and
recruits other proteins involved in DNA damage recognition and
repair [19,20]. Checkpoint recovery occurs when cells re-initiate cell
Figure 1. Systemic jnk2 deletion enhances tumor development. PyV MT/jnk2+/+ (n=12), PyV MT/jnk2+/2 (n=16), and PyV MT/jnk22/2 (n=19)
mice were palpated for mammary tumors thrice weekly. Once palpated, tumor growth was recorded thrice weekly. A). Kaplan Meier graph showing age of
first tumor palpation (median age was day 55 for PyV MT/jnk22/2 vs. day 70 for PyV MT/jnk2+/+, p=.11); B). Total number of tumors palpated per mouse
at the time of harvest was higher in PyV MT/jnk22/2 mice compared to PyV MT/jnk2+/+ mice, p=0.0192); C). Paraffin embedded, non-target tumor
sections were probed with cleaved caspase 3 primary antibody and detected using FITC labeled secondary antibody. Nuclei were stained with propidium
iodide. The total number of cells staining positive for cleaved caspase 3 were scored and divided by the total number of nuclei (n=5 tumors in each
group); D). Paraffin embedded tissue sections were probed with Ki-67 primary antibody and detected using DAB. Cells staining positive for Ki-67 were
counted and divided by the total number of nuclei (Hematoxylin) per field. Five fields per tumor were counted (n=5 per genotype, p=0.0159); E). Paraffin
embedded tissue sections were probed with p-c-Jun (Ser63) primary antibody and detected using DAB. Hematoxy l i nw a su s e da san u c l e a rs t a i n .
doi:10.1371/journal.pone.0010443.g001
JNK2 in Replicative Stress
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phosphatases which act upon proteins including pH2AX, see ref [19]
for review. JNKs were recently shown to directly phosphorylate
H2AX on Ser139 [21]. Therefore, we hypothesized that pH2AX
would be reduced in jnk2 knockout tumors.
Paraffin embedded tumors were probed with a pH2AX primary
antibody. PyV MT/jnk2+/+ tumors showed a notably higher
frequency of H2AX foci (individual foci could not be resolved). In
comparison, pH2AX foci in the PyV MT/jnk22/2 tumors were
much less frequent (Figure 3A). These data may be interpreted in
Figure 2. Target tumors obtained from PyV MT/jnk22/2 had increased aneuploidy. A). Tumors were finely minced and digested as
described in the Methods section. Cells were trypsinized at passage 2 to 3 and assessed for DNA content using PI staining. PyV MT/jnk22/2 tumors
contained more cells with DNA content $4N (PyV MT/jnk2+/+ (n=5), PyV MT/jnk22/2 (n=10), p=0.0485); B). Primary cells were treated with colcemid
and harvested to assess number of chromosomes per metaphase. The number and frequency of abnormal (aneuploid) chromosome numbers are
higher in PyV MT/jnk22/2 compared to PyV MT/jnk2+/+ (p=0.0043). Each colored bar represents a single target tumor obtained for an individual
mouse. The number to the right of the mouse number denotes the number of metaphases counted for each target tumor. The graph illustrates the
frequency of a particular chromosome number for each target tumor; C). Tumor lysates were subjected to SDS PAGE and western blotting using p53
primary antibody and detected using chemiluminescence. GAPDH primary antibody was used to assess similar loading amongst samples.
doi:10.1371/journal.pone.0010443.g002
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jnk22/2 tumors; 2). the PyV MT/jnk22/2 tumors have fewer
foci due to loss of JNK2 phosphorylation of pH2AX; or 3). the
PyV MT/jnk22/2 tumors show less DNA damage response and/
or a more rapid checkpoint recovery even in the presence of clear
differences in aneuploidy.
53BP1 is a key component in DNA damage checkpoint and
f u n c t i o n sa sab a r r i e rd u r i n ge arly tumorigenesis. 53BP1
localizes to DNA lesions initially recognized by pH2AX but
inactivation of 53BP1 and p53 occurs with tumor progression
and decreased apoptosis [22]. To validate our pH2AX findings
and to further address the presence of DNA damage or DNA
damage response, we probed tumor sections with a primary
53BP1 antibody and counted the fraction of cells with multiple
53BP1 nuclear foci (Figure3 B ) .A g a i n ,t h eP y VM T /jnk2+/+
tumors demonstrated a significantly higher fraction of cells with
53BP1 foci (Figure 3C). These data support that PyV MT/
jnk2+/+ tumors show either increased DNA damage or
increased repair response to DNA damage and cell cycle
resumption compared to the PyV MT/jnk22/2 tumors. These
data are also consistent with the reduced proliferation observed
in jnk2 knockout tumors shown in Figure 1.
Genetic deletions and amplifications occur more
frequently in PyV MT/jnk22/2 tumors
Next, we set out to further validate whether genomic instability
was higher in the PyV MT/jnk22/2 tumors. During tumorigen-
esis, error prone replication leads to DSBs and allelic imbalances
[22]. Given that JNK and ATM phosphorylate H2AX, and that
pH2AX commonly initiates a DNA damage response to allow
repair, we questioned if the PyV MT/jnk22/2 tumors harbor
more genetic mutations as a result of impaired pH2AX induced
DNA damage response or repair. Genomic DNA was isolated
from PyV MT/jnk2+/+, PyV MT/jnk22/2 tumors and non-
tumorigenic jnk22/2 and wild type mammary glands for
comparison of gene copy number changes using aCGH (array
Comparative Genomic Hybridization). Both tumor genotypes
showed gene deletions and/or amplifications compared to their
jnk2 matched normal mammary glands (Table 1), consistent with
the presence of genomic instability we observed in Figure 2. PyV
MT/jnk22/2 tumors showed additional chromosome segments
that were amplified or deleted compared to the PyV MT/jnk2+/+
tumors. Certain segmental changes were observed in multiple
pairs (similar segments are marked by common symbols, Table 1),
indicating that specific chromosome segments are targeted due to
functional significance (including growth selection) or unknown
structural similarities.
Subsequently, we focused on chromosome segments that were
hybridized by five or more probes and consistent with gene copy
number changes of one copy number or more. Table 2 shows
genes of interest (i.e. genes which have a role in cancer) resulting
from this analysis. Namely, DNA Ligase 1 (lig1) and Anaphase
Promoting Complex 5 (anapc5) gene copy numbers were reduced
by one copy or more in PyV MT/jnk22/2 tumors (Figure 4A).
This is consistent with either a complete loss of expression in
some but not all cell populations or a one copy number loss
throughout most of the tumor cells since samples are
heterogeneous. Validation using qPCR confirmed these findings
and measured approximately 50% reduction of lig1 and anapc5
in PyV MT/jnk22/2 tumors (Figure 4B). Similarly, an increase
in dmp-1 expression was validated in the PyV MT/jnk22/2
compared to PyV MT/jnk2+/+ tumors (data not shown). The
expression difference in sod2 (superoxide dismutase 2) was not
different using qPCR analysis. aCGH also indicated amplifica-
tion of a portion of the nrg3 (neuregulin 3) gene but we were
unable to amplify the product using qPCR, presumably due to
low abundance.
Figure 3. pH2AX and 53BP1 staining in PyV MT tumors. A).
Paraffin embedded PyV MT tumors were stained with pH2AX antibody
(green). Nuclei were counter stained with propidium iodide (PI, red);
Inset shows high magnification of a cell from a PyV MT/jnk2+/+ tumor
with arrows pointing at foci. B). Tumor sections were processed as in
A) except incubated with 53BP1 primary antibody. Images were
captured and pseudo-colored. 53BP1 antibody (red) and DAPI nuclear
stain (green). Inset shows high magnification of a cell from the PyV
MT/jnk2+/+ with arrows pointing at foci. C). Cells with $4 nuclear
53BP1 foci were counted as positive cells in each field; a minimum of 5
fields were counted/mouse. Each point represents a tumor average
(p=0.0286).
doi:10.1371/journal.pone.0010443.g003
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Chip No. Green Label Red Label Segment Segment Segment Segment Segment Segment
8802 PyVMT/jnk2+/+ jnk2+/+ Ctl Ch 5
{Del
94,530–96,030k
Ch 13
{Del
65,550–67,050k
Ch 14
1Del
3,150–5,250k
4702 jnk22/2 Ctl PyVMT/jnk22/2 Ch 3
Del
106,290–106,410k
Ch 4
*Del
111,570–
113,790k
Ch 7
yDel
7,050–7,410k
yDel
13,620–14,820k
Ch 14
Del
40,260–43,500k
0302 PyVMT/jnk2+/+ PyVMT/jnk22/2 Ch 4
*Amp
121,230–121,650k
Ch 5
{Del
94,470–96,030k
Ch 13
{Del
65,460–67,500k
3202 PyVMT/jnk2+/+ PyVMT/jnk22/2 Ch 17
VDel 6,210–6,390k
Del 12,900–13,380k
Del 16,710–17,010k
Ch X
pDel
24,450–25,950k
4502 PyVMT/jnk2+/+ PyVMT/jnk22/2 Ch 2
Del
174,660–177,540k
Ch 4
*Del
60,180–60,900k
*Del
111,540–113,460k
*Del
121,230–121,650k
Ch 5
Del
11,250–11,910k
Amp
104,820–105,060k
Ch 14
1Del
3,150–5,550k
Del
40,350–43,350k
Ch 17
VAmp
6,210–6,390k
Ch X
pDel
23,370–30,350k
7802 PyVMT/jnk2+/+ PyVMT/jnk22/2 Ch 3
Del
93,900–94,140k
Ch 4
*Amp
60,180–61,380k
*Amp
112,380–113,820k
*Amp
121,350–121,650k
Ch 5
{Del
94,740–95,700k
Ch 7
yDel
7,020–8,940k
yDel
13,620–14,820k
Ch 13
{Del
66,060–67,260k
doi:10.1371/journal.pone.0010443.t001
Table 2. Genes of interest on chromosomal segments.
Chromosome Segment Genes of Interest
2 174.7–177.5 M Similar to KRAB and zinc finger, C2HS type domain containing protein
4 60–61 M -
111–114 M Butyrophilin
121.3–121.7 M -
5 11–12 M Anapc5
94–96 M PRAME family
104–105 M Protein phosphatase, non-receptor type 13
Hydroxysteroid (17-beta) dehydrogenase 14
Dentin sialophosphoprotein, Dentin matrix protein 1, OPN, MEPE
SPARC-like 1 (mast9, hevin)
7 7–9 M Similar to actin-related protein 2
13–14 M Ligase I, DNA ATP dependent
13 65 M–67 M Similar to SWI/SNF chromatin remodeling protein subfamily e,
Similar to High mobility group protein 1 (HMG-1) (Amphoterin)
14 3–4 M -
40–43 M Neuregulin 3 (in part)
17 6–6.5 M Protein phosphatase, regulatory (inhibitor) subunit 2
12.9–13.4 IGF2 receptor,
MAS1 oncogene,
Wilm’s tumor-associated protein,
SOD2
X 23.4–30.4 M -
doi:10.1371/journal.pone.0010443.t002
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families which play integral roles in DNA damage response and
replication, namely, SWI/SNF, arp2 (actin related protein 2) and
PRAME (PReferentially expressed Antigen ofMElanoma) (Table 2).
Overall, aCGH analysis confirmed additional gene amplifications
or deletions in the PyV MT/jnk22/2 tumors compared to normal
mammary controls and the PyV MT/jnk2+/+ tumors. Some of the
genetic changes were observed in multiple tumor comparisons.
Specifically, lig1 and the arp2 related gene were deleted in PyV
MT/jnk22/2 tumor in comparison to jnk22/2 mammary gland
and PyV MT/jnk2+/+ tumors. Also, the SWI/SNF-type gene and
the PRAME family of genes differed in three pairs, including the
normal mammary comparison. Interestingly, Gorgoulis et al.
proposed that certain loci may be prone to DSBs which then lead
to genomic instability [22]. Our studies support the proposition that
specific loci are vulnerable during certain types of DNA damage. In
comparison to normal mammary tissue, DNA damage is higher in
PyV MT/jnk22/2 tumors.
Figure 4. Chromosomal and gene expression changes occur in PyV MT/jnk22/2 tumors. A). aCGH analysis of PyV MT/jnk22/2 tumors
show deletions in segments containing lig1, anacp5 and amplifications in dmp-1, amongst others, compared to PyV MT/jnk2+/+ controls; B).
Expression differences between PyV MT/jnk2+/+ and PyV MT/jnk22/2 tumors were compared for lig1 and anapc5 using qPCR amplification and
standard curves (n=5 per genotype).
doi:10.1371/journal.pone.0010443.g004
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cells
Cell lines were established from jnk2 wildtype and knockout
tumors to evaluate the role of JNK2 in replicative stress and DNA
damage. Subsequent characterization of the cell lines showed that
both lines are aneuploid. Genotyping confirmed the presence of
the PyV MT transgene, but PyV MT RNA and protein expression
were not detected using qPCR or western blot analysis (data not
shown), consistent with PyV MT gene silencing. Importantly, cell
proliferation did not differ widely between the cell lines when
cultured in 10% fetal bovine serum (FBS) containing medium
(data not shown).
To specifically address the role of JNK2 in replicative stress, cells
were serum starved for 24 hours and then stimulated with 10%
FBS. Cells were pulsed with bromodeoxyuridine (BrdU) for two
hours prior to harvesting. DNA BrdU incorporation was then
measured using flow cytometry. PyV MT/jnk2+/+ cells showed
approximately three-fold higher BrdU uptake for 12–18 hours after
addition of FBS (Figure 5A) which then decreased at 18–24 hours,
consistent with transit into G2/M. In contrast, PyV MT/jnk22/2
Figure 5. Serum treatment of G1 arrested cells induces cell death in PyV MT/jnk22/2 cells. A). PyVMT/jnk2+/+ and PyVMT/jnk22/2 cells
were serum starved for 24 hours and then treated with 10% FBS containing medium. Serum stimulated cells were pulsed with BrdU two hours prior
to harvesting and then stained with BrdU primary antibody followed by BrdU detection using flow cytometry. BrdU positivity data are presented as
percent positive cells in total cell population; B). PyVMT/jnk2+/+ and PyVMT/jnk22/2 cells were serum starved for 24 hours and then treated with
10% FBS containing medium. After 24 hours of serum starvation, cells were either cultured in fresh SFM or medium containing 10% FBS and
harvested 24 hours later. Cells were evaluated for Annexin positivity using flow cytometry. Data are expressed as percent positive cells of the total
population; C). Cells were serum starved as above and then harvested at indicated time points after 10% FBS stimulation to assess expression of
various cell cycle associated proteins using western blot analysis with primary antibodies directed towards the indicated proteins. GAPDH was used
to compare even sample loading.
doi:10.1371/journal.pone.0010443.g005
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negligible after 24 hours, showing that a smaller percentage of cell
successfully transited through S phase. Interestingly, the PyV MT/
jnk22/2 morphologically appeared to undergo cell death 18–
24 hours after serum addition. Indeed, FBS treated PyV MT/
jnk22/2 cells experienced higher Annexin positive staining
compared to the controls, untreated PyV MT/jnk22/2 cells and
the FBS treated PyV MT/jnk2+/+ cells (Figure 5B).
In light of these observations, the cells were treated in the same
fashion and harvested at several time points and compared to
asynchronously growing cells to evaluate expression of various cell
cycle associated proteins. Both cell lines showed phosphorylation
shifts of Rb protein (pRB) and increased expression of E2F1
associated with G1 to S phase transit in response to FBS treatment
but the expression of pRb and E2F1 (and other E2F proteins) was
lower in the PyV MT/jnk22/2 cells (Figure 5C). Notably, PyV
MT/jnk22/2 cells also showed higher and more sustained
p21Waf1 expression than the PyV MT/jnk2+/+ cells after FBS
treatment; whereas p53 expression was higher in PyV MT/jnk2+/+
cells. These data indicate that absence of jnk2 prevents cell cycle
re-initiation and/or S-phase transit. Increased p21Waf1 expression
is consistent with cell cycle slowing or arrest, however p53 does not
show the predicted increase in abundance necessary to induce
DNA repair and enhancement of p21Waf1 expression in PyV MT/
jnk22/2 cells.
The higher expression of p53 in PyV MT/jnk2+/+ cells may be
consistent with lack of p53 response in PyV MT/jnk22/2 cells or
expression of mutant p53 in the jnk2 wildtype cells. To functionally
evaluate p53, cells were treated with the DNA damaging agent
doxorubicin (which induces DSBs and ATM response) for
18 hours [23]. Figure 6A shows that both cell lines show enhanced
phosphorylation of p53 Ser15, the specific residue phosphorylated
by ATM/ATR (albeit higher in the PyV MT/jnk2+/+ cells).
Phosphorylation of H2AX was similarly observed in both cell lines,
indicating that ATM or ATR is likely mediating this effect even in
the jnk22/2 cells. Expression of p21Waf1, a p53 transcriptional
target, was also induced by doxorubicin treatment, but the
induction of expression was higher in jnk22/2 cells especially
relative p53 phosphorylation. Despite these differences, both cell
lines showed similar apoptotic responses to doxorubicin as
indicated by cleavage of caspase 3. These data support that both
cell lines express functional p53 and phosphorylation of ATM/
ATR substrates such as p53 and H2AX, in response to DNA
damage. Again, the PyV MT/jnk22/2 cells showed more robust
induction of p21
Waf1 relative to p53 activation. This disparity did
not lead to differences in cell death, indicating that jnk2 expression
does not mediate cellular response to DSBs but rather is specific to
cell death in response to cell cycle initiation.
Given that the PyV MT/jnk22/2 cells showed less phosphor-
ylation of the p53 Ser15 residue, we tested the role of ATM/ATR
in replication induced cell death using caffeine (an ATM/ATR
inhibitor) prior to and during FBS exposure. Figure 6B shows
that caffeine inhibited FBS induced cell death in the PyV MT/
jnk22/2 cells, whereas PyV MT/jnk2+/+ cells showed minimal
apoptosis in any group. Caffeine’s cytoprotection was associated
with lower p21
Waf1 expression and p53 Ser15 phosphorylation
in the jnk2 knockout cell line. Caffeine treatment also inhibited
p53 phosphorylation in the PyV MT/jnk2+/+ cell line but p21
Waf1
remained undetectable throughout (Figure 6C). These data
support that cell cycle induced DNA damage associated with
ATM or ATR activation leads to induction of p21
Waf1 and cell
death in the jnk2 knockout cells.
We then focused our studies more closely on the DNA
replication factor CDT1. CDT1 expression is necessary for
replication fork progression during S phase. Geminin inhibits
CDT1 to stall replication forks and allow G2/M transit. CDT1
degradation by proteases also facilitates this process. Lack of
CDT1 inhibition/degradation or overexpression of CDT1 results
in re-replication in some cell lines. In other cell lines, cell cycle
check points inhibit re-replication by activating ATR/Chk1
responses. Collapsed replication forks or overt re-replication can
lead to double strand breaks. ATM/p53 induction and increased
p21Waf1 expression are responses that prevent or repair DNA
damage [24].
As in previous studies, cells were serum starved and then
stimulated with FBS. Endogenous Similarly, CDT1 expression
was evaluated in a time dependent fashion along with p53 Ser15
phosphorylation and p21Waf1 expression. PyV MT/jnk2+/+ cells
increased CDT1 expression after serum treatment which de-
creased after 18 and 24 hours, consistent with G2/M transit
(Figure 7A). In contrast, PyV MT/jnk22/2 showed early and
sustained induction of p21
Waf1 and phosphorylated Chk1 which
were concurrent with increased CDT1 expression which contin-
ued for at least 24 hours after FBS addition. These responses
are indicative of replicative stress or prolonged S phase. In
jnk2 wildtype cells phosphorylation of p53 was preceded by
Chk1 phosphorylation, CDT1 and p21
Waf1 expression. Further-
more, Chk1 is only phosphorylated in PyV MT/jnk2+/+ cells in
late S phase, consistent with normal S phase transit and the fact
that Chk1 must become inactivated to recover from the
checkpoint arrest [25,26].
Overexpression of CDT1 initiates replication fork firing and
induces a ATR/Chk1 response [27]. The effectiveness of CDT1 to
induce replication fork firing is dependent upon its expression level
and on its binding to the inhibitory protein geminin and/or
degradation by Cul4-Ddb1
cdt2 or SCF
SKP2. Overexpression of
CDT1 was used to more closely assess the role of JNK2 during
replicative stress. Flow cytometric analysis showed that PyV MT/
jnk2+/+ underwent re-replication when CDT1 was overexpressed
compared to the PyV MT/jnk22/2 cells which did not
(Figure 7B). To evaluate check point response during replicative
stress, cells were left untreated, treated with hydroxyurea (HU,
another agent inducing replicative stress by stalling replicative
forks), or infected with adenoviral GFP or CDT1. Both cell lines
responded to HU exposure and CDT1 over-expression by
inducing phosphorylation of Chk1, an ATR substrate, showing
that they both have an intact response to replicative stress.
However, the PyV MT/jnk22/2 cells showed increased p21
Waf1
in response to HU or CDT1 over-expression compared to the PyV
MT/jnk2+/+ cells (Figure 7C). Cells were then serum starved and
treated with FBS along with CDT1 overexpression which further
induced p21
Waf1 expression in the PyV MT/jnk22/2 cells with
minimal effect on p53 Ser15 (Figure 7D). Conversely, PyV MT/
jnk2+/+ cells showed a more blunted p21
Waf1 response to FBS
and/or CDT1 overexpression and additive p53 Ser15 phosphor-
ylation when exposed to both. These data are all consistent with
the interpretation that loss of jnk2 expression is associated with
replication stress check point activation through ATR/Chk1 and
p21
Waf1 in a p53 independent fashion.
To ascertain if the differences observed in these cell lines were
due to jnk2 expression, the PyV MT/jnk22/2 cells were
transduced with GFP or GFP tagged JNK2a (the predominant
JNK2 isoform) expressing retrovirus (Figure 8A). GFP and GFP
JNK2a cells were then infected with increased inoculums of
CDT1 adenovirus, and phosphorylated Chk1 expression was
evaluated. Figure 8B shows that GFP expressing jnk2 deficient
cells showed an increase in Chk1 phosphorylation compared to
control GFP expressing cells (consistent with ATR dependency of
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PLoS ONE | www.plosone.org 9 May 2010 | Volume 5 | Issue 5 | e10443Figure 6. PyV MT/jnk22/2 cellular response is specific to replication and reversed by ATM/ATR inhibitor caffeine. A). PyVMT/jnk2+/+
and PyVMT/jnk22/2 cells were treated with doxorubicin at the indicated concentrations for 18 hours and then lysed. Expression of p21
Waf1, p-p53
(Ser15), pH2AX (Ser139), and cleaved caspase 3 were evaluated using western blot analysis. GAPDH was used to compare even loading amongst
samples; B). Cells were treated as described in A). except caffeine 2 mM was added as indicated; C). Cells were treated as described in A). except
caffeine 2 and 10 mM were added as indicated. Expression of p21
Waf1, p-p53 (Ser 15), and p53 were evaluated using western blot analysis. GAPDH
was used to compare even loading amongst samples.
doi:10.1371/journal.pone.0010443.g006
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PLoS ONE | www.plosone.org 10 May 2010 | Volume 5 | Issue 5 | e10443Figure 7. PyV MT/jnk22/2 cells experience replicative stress and increased p21
Waf1 expression. A). Cells were serum starved and
then harvested at different time points after 10% FBS stimulation to evaluate CDT1, p21
Waf1, p-Chk1 (Ser345), and p-p53 (Ser 15) expression by
western blot analysis using primary antibodies directed towards the indicated proteins. CDT1 expression at each time point was normalized to
GAPDH and graphed for PyVMT/jnk2+/+ and PyVMT/jnk22/2 cell lines; B). PyVMT/jnk2+/+ and PyVMT/jnk22/2 cell lines were infected with either
adenoviral-GFP or adenoviral-CDT1. Forty-eight hours later, cells were stained using PI with RNase, and then evaluated for cell cycle distribution using
flow cytometry; C). Cells were infected with either adenoviral-GFP or adenoviral-CDT1 and harvested 24 hours later. Alternatively, cells were treated
with hydroxyurea (HU 5 mM) for 24 hours and then harvested. Western blot analysis was used to measure pChk1 (Ser 345) and p21
Waf1 expression.
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expression of p21
Waf1. Interestingly, when p21
Waf1 is separated
using a higher percentage gel, a mobility shift is apparent in the
GFP-JNK2 re-expressing cells, consistent with a post-translational
change in p21
Waf1 when JNK2 is expressed. On the other hand,
phosphorylation of p53 Ser15 was lower in the GFP expressing
cells compared to the GFP-JNK2 re-expressing cells, mirroring
our previous observation with the PyV MT/jnk2+/+ cells. In
summary, these data further validate that loss of JNK2 causes an
early cell cycle checkpoint via p21
Waf1 and Chk1 phosphorylation.
Replicative stress induces p21
Waf1, which delays or prevents re-
replication, subsequent DSBs, and p53 response and repair.
Without the appropriate induction of p53 response and repair
functions, cells are unable to resume the cell cycle and undergo cell
death.
These data suggest that JNK2 responds early or directly to
replicative stress to influence DNA damage response and repair.
During replicative or UV induced stress, RPA (a heterotrimeric
protein) localizes to the DNA lesions or stalled replication forks.
Phosphorylated Rad17 then translocates to the RPA modified,
DNA strands [28], see refs [29,30] for review. Subsequently,
Rad17 recruits the 9-1-1 complex which induces DNA ligase 1
activity for repair [31]. For this experiment UV treatment was
used to induce discrete DNA lesions to visualize foci microscop-
ically. Cellular response to UV causes ssDNA lesions and initiates
RPA coating of ssDNA. By causing ssDNA, UV treatment also
leads to replication fork arrest and induces ATR activity [32].
Significantly, ATR phosphorylates p21
Waf1 on Ser114 which is
important for cdt2 degradation in response to UV treatment [33].
We hypothesized that JNK2 would localize to DNA breaks
during UV induced DNA damage. For these studies, we aimed to
evaluate normal DNA damage response by treating noncancerous,
human MCF10A cells with UV irradiation. After UV treatment,
RPA concentrated in specific areas of the nucleus consistent with
its ability to coat ssDNA. After UV treatment, JNK2 and DNA
Ligase 1 (Lig1) translocated from the cytoplasm to the nuclear
RPA coated lesions (Figure 8C, Panel A). Panel B shows that
JNK2 and DNA Ligase 1 co-localize to the same nuclear regions.
The co-localization of JNK2 and DNA ligase 1 are specific to UV
induced, RPA coated ssDNA lesions since they do not co-localize
with PCNA (Panel C). Finally, confocal microscopy was used to
further comfirm co-localization of JNK2 and DNA ligase 1 in
response to UV treatment (Panel D). Together, these data support
a role for JNK2 in sensing replicative stress and engaging
subsequent repair mechanisms through p53 and other DNA
repair responses.
Discussion
Herein, we describe an oncogene induced mouse mammary
tumor model where mice lacking jnk2 experience higher tumor
multiplicity and genomic instability. Unexpectedly, PyV MT/
jnk22/2 had lower cell proliferation rates but there are likely
several considerations to the finding. For example, the PyV
MT/jnk22/2 tumors expressed less phosphorylated c-Jun
(shown in Fig 1E) which induces a variety of proliferation
related genes like cyclin D and c-myc. As noted, PyV MT/
jnk22/2 tumors also express less DNA ligase 1. Its high
expression level has been associated with increased proliferation
rate in cancer cells [34,35]. Lastly, increased p21
Waf1 expression
may contribute to less proliferation. Since cells cannot be
synchronized in vivo due to constitutive expression of PyV MT, it
is difficult to evaluate cell cycle changes in tumors. Therefore,
we studied cell lines derived from these tumors. In vitro
experiments mechanistically support that PyV MT/jnk22/2
cells experience replicative stress when stimulated to re-initiate
the cell cycle. Cells lacking jnk2 induce p21
Waf1 and pChk1 prior
to p53 activation to prevent re-replication. This response
induces cell death in an ATR/ATM dependent fashion, as it
is inhibited by caffeine.
Our in vivo data show that loss of jnk2 leads to earlier and more
frequent tumorigenesis. Tumors lacking jnk2 showed more
genomic instability, aneuploidy, and impaired DNA damage
response/repair, perhaps due to a reduction or loss of DNA ligase
1 mediated response/repair during replicative stress. DNA ligase 1
expression increases during proliferation, and it binds to PCNA to
join Okazaki fragments. DNA ligase 1 also mediates long-patch
base excision repair and participates in the 9-1-1 (a checkpoint
complex containing Rad9, Hus1 and Rad1) DNA damage
response to repair single stranded DNA damage during replicative
stress [36,37,38]. DNA Ligase 1 binds to Rad17 during S phase,
concomitant with DNA damage [37]. Together, these properties
suggest a dependence on DNA ligase 1 in tumor cells during
oncogene induced replicative stress. Other investigators have also
shown a link between JNKs and DNA ligase 1. Using siRNA
targeting of JNK1 and JNK2, and a JNK pharmacologic inhibitor,
lig1 expression was changed, along with several other DNA repair
genes, in reponse to cisplatin treatment [39]. In breast tumors and
MEFs containing Rb/E2F mutations, DNA ligase 1 and other
replication factors’ expression are altered [40]. Together, these
studies support that JNK2 is important in DNA damage response
possibly via regulation of lig1 expression, activation of ATR/
Chk1/p21
Waf1 response and co-localization with these proteins to
ssDNA lesions.
Reduction in DNA ligase 1 function may not be the only event
that contributes to the more tumorigenic phenotype observed. A
reduction in a SWI/SNF related gene was also observed along
with a reduction in a gene similar to arp2. Together, these proteins
are known to be important for chromatin remodeling during
replication and DNA damage [41,42]. Futhermore, APC5
(product of anapc5) is part of a multisubunit ubiquitin ligase that
mediates protein degradation during transit through G1 and
mitosis. In Drosophila, IDA/APC5 mutants display aneuploidy
without cell cycle arrest [43].
We speculate that the genomic instability observed is limited to
the tumors rather than a general effect. Jnk22/2 mice (lacking
expression of the PyV MT transgene) do not show overt
phenotypes that would suggest the presence of genomic instability
such as the atm2/2 mice. To further evaluate the possibility that
loss of jnk2 may be causative to genomic instability, we also
compared the ploidy status of Mouse Embryo Fibroblasts (MEFs)
after inducing G1 arrest to evaluate DNA content. Both the
jnk2+/+ and jnk22/2 MEF lines were aneuploid (data not shown).
This observation is likely due to the genomic instability of mouse
cell lines with in vitro culture.
Previously, we reported that inhibition of JNK leads to
endoreduplication in a p53 independent fashion using human
breast cancer cell lines [9]. Similarly, MacCorkle and Tan
GAPDH was used to compare sample loading; D). Cells were infected with either adenoviral-GFP or adenoviral-CDT1 during 24 hours of serum
starvation then stimulated with 10% FBS and harvested 24 hours later. pChk1 (Ser 345), p-p53 (Ser15), and p21
Waf1 expression was evaluated using
western blot analysis. GAPDH was used to compare sample loading.
doi:10.1371/journal.pone.0010443.g007
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PLoS ONE | www.plosone.org 12 May 2010 | Volume 5 | Issue 5 | e10443Figure 8. JNK2 is integral in sensing replicative stress and localizing at RPA coated lesions. A). PyVMT/jnk22/2 cells were infected with
JNK2a retrovirus and selected using puromycin. GFP-JNK2 expression was measured using JNK2 primary antibody and PyVMT/jnk2+/+ lysates as
positive a control; B). PyVMT/jnk22/2 and PyVMT/jnk22/2GFP-JNK2a expressing cells were infected with increasing doses of GFP-CDT1. Cells were
processed as described in C). Cell lysates were analyzed for pChk1 (Ser 345), p53 (Ser 15) and p21
Waf1. GAPDH was used to compare even sample
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human cancer cell lines [44]. We hypothesize that PyV MT and
CDT1 overexpression cause replication under nonpermisive
conditions to induce tumorigenesis. The absence of JNK2 further
enhances replicative stress, genomic instability and tumorigenesis
to ensue. Using established early-passage, cell lines derived from
PyV MT tumors we were able to synchronize cells in G1 phase
and follow cell cycle progression after FBS treatment (due to
silencing of PyVMT expression). These studies showed that jnk2
knockout cells induce p21
Waf1 prior to p53 activation as shown by
Ser15 phosphorylation. Overexpression of CDT1 further support-
ed that the jnk2 knockout cells underwent Chk1 and p21
Waf1
induction in response to replicative stress, while re-expression of
JNK2 inhibited Chk1 phosphorylation. During oncogene induced
replicative stress and/or senescence, activation of p53 and Chk1
are increased to mediate damage repair, and p53 induced
expression of p21
Waf1 contributes to senescence. Surprisingly,
PyV MT/jnk22/2 underwent cell death in response to replicative
stress. This response may be due to an inefficient DNA damage
response or repair associated with inadequate p53 or 9-1-1
reponse during replicative stress. Alternatively, others have
reported that c-jun deficient cells undergo premature senescence
resulting from DNA damage accumulation and inefficient repair
[4]. Any or a combination of these responses would likely deter
DNA repair and subsequently result in cell death. The presence of
replicative stress and genomic instability is consistent with our in
vivo model and reduced pH2AX and 53BP1 foci suggest a lack of
DNA repair or response mechanisms in these tumors. We did not
observe differences in cell death in tumors perhaps because cells
grew asynchronously.
Consistently, jnk2 knockout cells showed robust induction of
p21
Waf1 in vitro which did not correlate with p53 Ser15
phosphorylation. The ability of caffeine to inhibit cell death and
p21
Waf1 expression in the PyV MT/jnk22/2 cells supports a role
for ATR in this response and places JNK2 as an intermediary
between these kinases and p53/p21
Waf1 effects. While p53 is usually
attributed to an increase in p21
Waf1 expression, other p53
independent mediators exist, including c-myc, Notch, ETS
transcription factors, histone acetylation inhibitors, ATM, and c-
Jun, amongst others [45]. Alternatively, our data mostly support
that post-translational mechanisms contribute to this reponse. In
JNK2 re-expressing cells, p21
Waf1 underwent a mobility shift which
may be due to phosphorylation. In fact, other investigators have
reported p53 independent increases in p21
Waf1 using similar models
[46,47]. There are a variety of explanations for the discordance
between p53 and p21
Waf1 responses during replicative stress. Most
of these are related to mechanisms of p21
Waf1 protein stability. For
instance, MCM, geminin and CDT2 depletion lead to p21
Waf1
accumulation and cell cycle checkpoint in a p53-independent
manner [48,49]. Abbas et al concluded that CDT2 facilitates DNA
repair by degrading p21
Waf1 [48]. Several kinases have been
reported to phosphorylate p21
Waf1, including Akt1 on Thr145 and
Ser146 [50,51] which inhibits p21
Waf1 binding to PCNA and
CDK2/4, indirectly enhancing cell proliferation. CDK2-cyclin E
and GSK3 can also phosphorylate p21
Waf1 on Ser130 and Thr57,
respectively. Lastly, ATR phosphorylates p21
Waf1 on Ser114 which
is important for CDT2 degradation in response to UV treatment
[33]. Phosphorylation of p21
Waf1 reduces its stability. SCF
SKP2
degrades phosphorylated p21
Waf1 bound to CDK2 during G1/S
and S phase transit. CRL4
cdt2 also degrades phosphorylated
p21
Waf1 when it’s bound to PCNA during S phase or in response
to UV treatment [52]. Our studies suggest that JNK2 may directly
phosphorylate p21
Waf1 or enhance activity of other kinases which
phosphorylates p21
Waf1 to facilitate cell cycle transit.
Future studies will be aimed at understanding the influence of
JNK2 in these responses and specifically addressing whether or not
inhibition of JNK2 may be targeted therapeutically to enhance
tumor cell death or senescence. Our data with JNK2 align with the
paradoxial effects of oncogene expression wherein oncogene
expression often faciliates cell replication but under certain
conditions it ultimately induces a response that is incompatible
with cell cycle transit.
Materials and Methods
Mouse tumorigenesis studies
FVB PyV MT mice were obtained from Dr. Bill Muller (McGill
University, Montreal, Canada). All animal experiments were
conducted according to institutional guidelines at the University of
Colorado Health Sciences Center and the University of Texas,
Austin. Jnk22/2 C57/BL6 mice and PyV MT mice were
backcrossed into the Balb/C strain for over 10 generations.
Female Balb/C mice with the genotypes PyV MT/jnk2+/+, PyV
MT/jnk2+/2, and PyV MT/jnk22/2 were palpated three times
weekly until the largest of palpable tumors (the ‘‘target’’ tumor)
reached 150 mm
3. At this point the mouse was euthanized, and all
tumors, mammary glands, and lungs were harvested according to
an approved IACUC protocol.
Western blot analysis
Flash frozen tumors were homogenized in cold EB buffer
(20 mM Tris-HCl, 250 mM NaCl, 3 mM EDTA, 0.05% Ipegal,
1 mM dithiothreitol, 0.368 mg/ml Na orthovanadate, 5 mg/ml
leupeptin, 1 mM phenylmethylsulfonyl fluoride, and 17 mg/ml
aprotinin) followed by centrifugation at 13,000 g to remove
cellular debris. Fifty to 60 mcg of total cell lysate were resolved by
SDS-PAGE and transferred to nitrocellulose. Western blot
analyses were performed using primary antibodies to p53
overnight at 4uC, and later incubated with secondary antibody.
Protein expression was detected using chemiluminescence with a
Storm 860 Phosphorimager (GE Electronics). GAPDH expression
was used as loading control for comparison of equal protein
loading amongst samples.
Primary tumor cell isolation and metaphase spreads
Tumor tissue was minced into 1 mm
3 pieces with a sterile
scalpel. Tissue fragments were washed with Dulbecco’s Phosphate-
Buffered Saline, and then re-suspended with 0.5 mg/ml collage-
nase A (Roche) containing serum-free media. Cells were incubated
in a water bath shaker at 37uC, at 80 rpm overnight. The
following day the suspension was centrifuged at 300 g for 5 min at
4uC. Cells were re-suspended in primary culture media (DMEM/
F-12 (Mediatech Inc.) supplemented with 2% FBS (Benchmark),
1 mg/ml BSA (Sigma), 10 ug/ml insulin (Lilly) and 5 ng/ml EGF
(Peprotech)). The cells were then cultured for 2 to 3 days at 37uC
in a 5% CO2 incubator. Cells were filtered through a 70 micron
Nylon mesh before splitting the second time. Cells from each
tumor were used for cell cycle analysis and metaphase analysis.
loading. C). MCF10A cells were plated in chamber slides, untreated or treated with UV (10 J/m
2), and fixed 2 hrs later. Cells were incubated with RPA,
DNA Ligase 1 (Lig1), PCNA, or JNK2 primary antibodies, as indicated, followed by incubation with FITC or Texas Red secondary antibodies, (G) Green,
(R) Red. Panel D includes images acquired using confocal microscopy. Co-localization was evaluated using color overlay.
doi:10.1371/journal.pone.0010443.g008
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Logarithmically growing primary tumor cells (passage 2–3) in
10 cm
2 culture dishes were treated with colcemid (Sigma) for 55
minutes at 37uCi n5 %C O 2. Briefly, cells were collected using
trypsin and re-suspended in 0.075 M KCl and incubated at room
temperature for 20 minutes. The cells were re-suspended in ice
cold Modified Carnoy’s repeatedly four times and finally
incubated overnight at 220uC. Cell suspensions were dropped
onto glass slides and aged overnight at room temperature. Slides
were then stained with Geimsa and trypsin + EDTA (0.25%).
Metaphase spreads were visualized using a Nikon Diaphot 300
Microscope and a 1006oil objective.
Cell cycle studies
Cell cycle distribution of primary tumor cells was measured
using a Cytomics FC500 flow cytometer (Beckman Coulter)
equipped with an argon laser with emission wavelength at 488 nm.
Fluorescence of propidium iodide (PI) was collected using a 585/
42 band-pass filter. A maximum of 50,000 events was collected
from each sample. Analysis of the cell cycle compartments was
carried out using CXP analysis software.
Histology and Immunohistochemistry
For tumor sections, 5 micron, paraffin-embedded tissue sections
were either stained in hematoxylin and eosin or used for
immunohistochemistry with Ki-67 (Neomarkers), cleaved cas-
pase-3, pH2AX (S139) (Calbiochem), p-cJun (S63) (Cell Signal-
ing), or 53BP1 (Bethyl Laboratories) as indicated. Expression of
proteins was detected by using DAB (Vector Labs) or fluorescence.
Hematoxylin and propidium iodide staining were used as nuclear
markers. Fluorescent images were captured on a Nikon Diaphot
inverted microscope using a CoolSnapfx camera and ImagePro
6.1 software for color overlay.
qPCR of lig1, and anapc5
Lig1 and anapc5 measurements were generated from target
tumors. 18S was used as a loading control for tumor samples.
Samples were amplified using SYBR green fluorescence on a
Stratagene Mx3005p (Agilent Technologies Company).
Array Comparative Genomic Hybridization (aCGH)
Genomic DNA was isolated from tumors using Gentra Pure-
gene Tissue Kit (Qiagen). Samples were then hybridized and data
generated using Roche Nimblegen services and technology.
Cell lines and JNK2 Overexpression
PyV MT/jnk2+/+ and PyV MT/jnk22/2 cell lines were
derived from mammary tumors. Cells were maintained in
DMEM/F12 (1:1) medium (Mediatech Inc.) supplemented with
10% FBS (Benchmark), 10 ug/ml insulin (Lilly), 5 ng/ml EGF
(Peprotech), 5 mg /ml linoleic acid (Biosource), 50 mg/ml genta-
micin, 100 units/ml penicillin, and 100 mg/ml streptomycin
(Invotrogen). PyV MT/jnk22/2 cells were reconstituted with
GFP-tagged mouse JNK2a protein, or GFP empty vector. The
cells were cultured in medium, containing 2 mg/ml puromycin.
Cells were synchronized in defined serum free medium (DMEM/
F12 medium containing 2 mg/ml transferrin, 2 mg/ml human
fibronectin (BD Biosciences) and 16 trace elements (Biosource))
for 24 hours.
Antibodies and Western Blot Analysis
Anti-53BP1 (Bethyl laboratory Inc., Montgomery, TX), anti-
JNK2 (D2) and anti-CDT1 (Santa Cruz Biotechnology, CA), anti-
cleaved caspase 3 (Cell Signaling Technology, MA), anti-p53
(Imgenex, San diego, CA), anti-Rb, anti-p21
Cip1 (BD Pharmingen,
San Jose, CA), and mouse anti-GAPDH (Advanced Immuno-
Chemical Inc.) antibodies were used for western blot analysis. Anti
phospho-c-Jun (Ser63), anti-phospho-p53 (Ser15), anti- phospho-
CHK1 (Ser345), anti- phospho-H2AX (Ser139) antibodies were
used for detecting the specific phosphorylated proteins. Proteins
were detected by enhanced chemiluminescence (ECL) kit
(Amersham Pharmacia Biotech, NJ).
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